Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by smallcapcanadaon Jun 07, 2018 10:19am
321 Views
Post# 28138975

Is Aurora Trying to do too Much?

Is Aurora Trying to do too Much?
Another day and another strategic agreement for Aurora, announcing this morning that they struck a deal with Capcium Inc. to produce high quality cannabis-based softgels for patients.

No surprise to anyone who follows Aurora, they also acquired a 19.99% ownership interest in Capcium by way of a non-brokered private placement for consideration of $10 million.

$9.5 million of that will be paid in common shares.

As much as Aurora has done to grow, and they have struck some very impressive deals no question, there still has to be concern over dilution at this point- maybe it's time to slow down a minute, not fight for headlines every day, and concentrate on the current operations.

Is that too much to ask or should they continue down this path?

SmallCapCanada (.com)
Bullboard Posts